Boehringer R&D work booms in Connecticut

The Hartford Courant takes a close look at Boehringer Ingelheim's R&D work underway in Connecticut. While other Big Pharma companies have been cutting R&D efforts, Boehringer has been beefing up its research staff every year over the past three years. It currently has 1,300 staffers working in the state, and it plans to open a new building and hire even more in 2009.

"Being a private company, it is different," Phil Vickers, senior vice president and head of research for Boehringer in Ridgefield tells the Courant. "It allows us to implement longer-term strategies for research."   

- read the report in the Hartford Courant

Related Articles:
Boehringer boasts of late-stage drug potential
Boehringer wins approval in anti-clotting drug race
Boehringer Ingelheim - Top 13 Advertising Budgets